TMIC-28. GLIOBLASTOMA EXPLOITS CELL SURFACE GLYCOSYLATION-MEDIATED IMMUNE REGULATORY CIRCUITS FOR IMMUNE ESCAPE. (5th November 2018)
- Record Type:
- Journal Article
- Title:
- TMIC-28. GLIOBLASTOMA EXPLOITS CELL SURFACE GLYCOSYLATION-MEDIATED IMMUNE REGULATORY CIRCUITS FOR IMMUNE ESCAPE. (5th November 2018)
- Main Title:
- TMIC-28. GLIOBLASTOMA EXPLOITS CELL SURFACE GLYCOSYLATION-MEDIATED IMMUNE REGULATORY CIRCUITS FOR IMMUNE ESCAPE
- Authors:
- Dusoswa, Sophie
Verhoeff, Jan
Abels, Erik
Breakefield, Xandra
Noske, David
Würdinger, Tom
Broekman, Marike
Van Kooyk, Yvette
Garcia-Vallejo, Juan - Abstract:
- Abstract: Glioblastoma is the most aggressive brain malignancy, for which conventional therapy has failed to achieve major improvements in survival since 2005. Glioblastoma-associated immune infiltrates are dominated by tumour-associated macrophages (TAM), which could be the key mediators of immune suppression. Recently we proposed the tumour "glyco-code" as a novel target for immunotherapy, and source for biomarkers. Malignant transformation is associated with aberrant expression of cell surface glycans, which play crucial roles in processes such as migration, angiogenesis and immune modulation. Here we investigated the glioblastoma glycocalyx as a tumour-intrinsic immune suppressive mechanism via tumour infiltrating macrophages. We detected increased expression of tumour-associated truncated O-linked glycans in patient-derived glioblastoma- versus control tissues by immunofluorescence and ELISA based assays. In concert, the macrophage galactose lectin (MGL) receptor, which interacts with truncated O-linked glycans, was overexpressed on glioblastoma infiltrating TAM, also detected by immunofluorescence, and confirmed on RNA level in TCGA data. Unsupervised, high-dimensional mass cytometry (CyTOF) analysis of a murine immunocompetent orthotopic glioblastoma model overexpressing truncated O-linked glycans revealed increased tumor infiltration by CCR2+, PD-L1+ macrophages. At a systemic level, we discovered increased frequencies of CCR2+ peripheral dendritic cells (pDC), and aAbstract: Glioblastoma is the most aggressive brain malignancy, for which conventional therapy has failed to achieve major improvements in survival since 2005. Glioblastoma-associated immune infiltrates are dominated by tumour-associated macrophages (TAM), which could be the key mediators of immune suppression. Recently we proposed the tumour "glyco-code" as a novel target for immunotherapy, and source for biomarkers. Malignant transformation is associated with aberrant expression of cell surface glycans, which play crucial roles in processes such as migration, angiogenesis and immune modulation. Here we investigated the glioblastoma glycocalyx as a tumour-intrinsic immune suppressive mechanism via tumour infiltrating macrophages. We detected increased expression of tumour-associated truncated O-linked glycans in patient-derived glioblastoma- versus control tissues by immunofluorescence and ELISA based assays. In concert, the macrophage galactose lectin (MGL) receptor, which interacts with truncated O-linked glycans, was overexpressed on glioblastoma infiltrating TAM, also detected by immunofluorescence, and confirmed on RNA level in TCGA data. Unsupervised, high-dimensional mass cytometry (CyTOF) analysis of a murine immunocompetent orthotopic glioblastoma model overexpressing truncated O-linked glycans revealed increased tumor infiltration by CCR2+, PD-L1+ macrophages. At a systemic level, we discovered increased frequencies of CCR2+ peripheral dendritic cells (pDC), and a decrease in CCR2+ monocyte frequencies in the bone marrow of these mice. Moreover, we observed a drastic increase in correlations between glioblastoma infiltrating CCR2+ macrophages and several myeloid cell subsets in the bone marrow using network analysis of frequency correlation statistics. Our results suggest that glioblastomas overexpress truncated O-linked glycans and exploit cell surface glycosylation- mediated immune regulatory circuits for systemic immune modulation and recruitment of suppressive TAM. … (more)
- Is Part Of:
- Neuro-oncology. Volume 20(2018)Supplement 6
- Journal:
- Neuro-oncology
- Issue:
- Volume 20(2018)Supplement 6
- Issue Display:
- Volume 20, Issue 6 (2018)
- Year:
- 2018
- Volume:
- 20
- Issue:
- 6
- Issue Sort Value:
- 2018-0020-0006-0000
- Page Start:
- vi262
- Page End:
- vi262
- Publication Date:
- 2018-11-05
- Subjects:
- Brain Neoplasms -- Periodicals
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481 - Journal URLs:
- http://neuro-oncology.dukejournals.org/ ↗
http://neuro-oncology.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/content?genre=journal&issn=1522-8517 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/neuonc/noy148.1087 ↗
- Languages:
- English
- ISSNs:
- 1522-8517
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.288000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12255.xml